Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Media Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Filter
News
Articles
Podcasts
Infographics
GSK pledges £45m to new antimicrobial resistance initiative
GSK has pledged £45m to the Fleming Initiative, a UK scheme to tackle antimicrobial resistance, led by Imperial College Healthcare NHS Trust and Imperial College London.
Read more
Spoonful of technology: September 2023
Learn about the top healthcare technology stories of the past few months, highlighting four innovative examples of how companies are harnessing artificial intelligence to benefit key stakeholders.
Spotlight: April–August 2023
Take a look back at some of the top news stories from the pharmaceutical industry over the last few months, including regulatory approvals, governmental schemes and much more.
UK unveils new health security strategy
The UK Health Security Agency launched its 10-year science strategy on 16 May 2023, detailing plans to protect UK from present and future health threats.
Spoonful of technology: April 2023
GOLD reviews the top stories in health technology from the past few months, highlighting four innovative examples of how tech is changing treatment landscapes and patient experiences today.
UK generics body wants in on VPAS talks
The BGMA has launched legal action over the decision to only grant it ‘observer’ status in the upcoming VPAS negotiations. Read more.
Spotlight: January-April 2023
GOLD looks back at some of the top news stories from the pharmaceutical industry over the last few months, covering landmark therapy approvals, insulin price cuts and much more.
Eli Lilly improves cold chain capacity
Eli Lilly has pledged over $1m to improve cold chain capacity for insulin in low- to middle-income countries.
Pharma voted second most trusted industry in Britain
The pharmaceutical industry is the second most trusted sector in Great Britain, according to the latest Ipsos Trustworthiness Index.
Loading posts...
« Previous
1
2
3
4
5
…
8
Next »